The import of insulin in dosage forms to the UK is forecasted to grow steadily from 2024 to 2028, with values increasing from 1.9834 million kilograms in 2024 to 2.1265 million kilograms in 2028. In 2023, the value stood at 1.9474 million kilograms, marking the base year for our analysis. The year-on-year (YoY) increases are as follows:
- 2024: +1.85%
- 2025: +1.86%
- 2026: +1.79%
- 2027: +1.73%
- 2028: +1.66%
The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is approximately 1.78%, indicating a modest but steady growth in insulin imports.
Future trends to watch for include advancements in insulin medication, potential changes in trade regulations post-Brexit, and shifts in global insulin supply chains which could impact import volumes. Additionally, monitoring changes in domestic insulin production capacities will be essential in understanding future import needs.
